Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome  Michel De Vos,

Similar presentations


Presentation on theme: "Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome  Michel De Vos,"— Presentation transcript:

1 Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome  Michel De Vos, M.D., Ph.D., Carolina Ortega-Hrepich, M.D., Firas K. Albuz, Ph.D., Luis Guzman, M.Sc., Nikolaos P. Polyzos, M.D., Ph.D., Johan Smitz, M.D., Ph.D., Paul Devroey, M.D., Ph.D.  Fertility and Sterility  Volume 96, Issue 4, Pages e1 (October 2011) DOI: /j.fertnstert Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

2 Supplemental Figure 1 Flowchart describing the interventions associated with IVM treatment in the study cohort. Fertility and Sterility  , e1DOI: ( /j.fertnstert ) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions


Download ppt "Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome  Michel De Vos,"

Similar presentations


Ads by Google